Clinical Analysis of 635 Cervial Smesr Using Thinprep Cytologic Test and the Betheasda System
- VernacularTitle:液基超薄细胞技术及TBS系统检验635例宫颈涂片临床分析
- Author:
Xia LI
- Publication Type:Journal Article
- Keywords:
Cervial smesrs;
Thinprep cytologic test;
Betheasda system;
Human papilloma virus
- From:
Journal of Medical Research
2006;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the clinical value of thinprep cytologic test(TCT)and the Bethesda system(TBS)for the diagnosis of early cervical diseases.Methods A total of 635 patients in our hospital had been examined by TCT and TSB from December 2005 to 2006.the abnormal cases which had been selected by TCT were detected by colposcopical pathological examination and Hybrid Capture Ⅱ HPV testing.Results We found 66(10.23%)abnormal smears out of 635 cases,in which atypical squamous cell of undetermined significance(ASCUS)37 cases(5.83%),low grade squamous intraepithelial lesion(LSIL)18cases(2.80%),high grade squamous intraepithelial lesion(HSIL)10 cases(1.57%),quamous cellcarcinoma 1case(0.16%).The rates of coordinance with pathological results of colposcopy and HCⅡ were 92.95% and 87.00% respectively.Conclusions TCT and TBS,sometimes combined with the colposcspy and HPV DNA test,may be a reliable method to screen and diagnose the precancerosis of cervix.
